Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




DSL Acquires Oxford Bio-Innovation

By HospiMedica staff writers
Posted on 12 Nov 2001
In a move that will complement its line of fertility products, Diagnostic Systems Laboratories (DSL; Webster, TX, USA) has acquired Oxford Bio-Innovation Ltd. More...
(OBI, Oxford, UK). Terms were not disclosed.

OBI makes and markets diagnostic and research products and has a clinical testing service. Its products include kits and reagents for inhibin A, inhibin B, and activin, all of which play a role in male infertility, assessment of ovarian reserve, prediction of in vitro fertilization (IVF) outcomes, and differential diagnosis of ovarian cancer. The tests are used by clinical and research laboratories worldwide.

DSL develops and manufactures products for global clinical, research, academic, and veterinary markets and currently offers more than 190 immunoassay products. These include tests for fertility and reproduction, thyroid function, growth factors, and bone and mineral metabolism.

"The acquisition of OBI positions DSL as the exclusive global provider of diagnostic tests for the measurement of inhibins and activins,” said Gopal V. Savjani, CEO of DSL.
"DSL's strength in the field of reproductive endocrinology combined with OBI's focus and experience in the area of inhibins and activins will enable us to accelerate the development of additional products and clinical applications in this field.”




Related Links:
DSL

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Thyroid Test
Anti-Thyroid EIA Test
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.